GlobeNewswire Inc.T3·22d ago
LSTA Lisata Therapeutics, Inc. Common Stock
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
LSTA
—
—
Key stats
Related
About
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 21
- List Date
- 1999-03-01
- CIK
- 0000320017
- Next Earnings
- 2026-11-05
- Headquarters
- Basking Ridge, NJ
- Homepage
- https://www.lisata.com
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|
| Jan | -- | 38.76% | -11.15% | -29.96% | 136.22% | 33.47% |
| Feb | -- | -12.47% | 8.52% | -7.75% | -10.09% | -5.45% |
| Mar | -- | 7.10% | 0.65% | 9.30% | 14.38% | 7.86% |
| Apr | -- | 0.00% | -11.91% | 9.72% | -37.72% | -9.98% |
| May | -- | 25.77% | 3.04% | 8.31% | 3.83% | 10.24% |
| Jun | -- | -12.94% | 14.71% | 5.81% | -5.03% | 0.64% |
| Jul | -- | -10.20% | -9.42% | -13.29% | -70.62% | -25.88% |
| Aug | -- | -31.87% | -13.94% | -6.83% | 43.27% | -2.34% |
| Sep | -25.92% | -1.83% | 7.53% | 18.55% | -8.28% | -1.99% |
| Oct | -6.40% | 1.88% | -3.41% | 13.88% | -28.86%* | -4.58% |
| Nov | -17.26% | 3.30% | -12.66% | -22.85% | -- | -12.37% |
| Dec | -29.72% | 21.33% | 7.58% | -7.46% | -- | -2.07% |
| Total | -59.68% | 9.23% | -23.13% | -30.85% | -59.03% | -32.69% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $1.16
SMA 50: $1.40
SMA 200: $3.01
Current: $1.06
EMA 12: $1.08
EMA 26: $1.21
MACD: -0.1289 | Signal: 0.0051
BEARISH
ADX (14): 9.43
RANGE
+DI: 23.88
−DI: 23.22
Momentum Oscillators
RSI (14): 39.33
NEUTRAL
Stoch %K: 15.68
Stoch %D: 13.41
Williams %R: -71.51
Volume & Volatility
BB Upper: $1.50
BB Lower: $0.82
NEUTRAL
OBV: 12,798,665
Vol SMA 20: 110,570
Vol ROC: -63.81%
ATR: $0.12
True Range: $0.10
HV 20: 85.4%
HV 30: 95.9%
HV 60: 119.1%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
Here is my comprehensive stock analysis report for LSTA:
Executive Summary
BULLISH/BEARISH: NEUTRAL (6/10)
Key drivers: Oversold RSI, strong trend indicators, and low volatility.
Primary risks: Bearish MACD signal, negative news sentiment, and potential catalysts that could impact the stock price.
Investment thesis: LSTA is likely to experience a short-term rebound due to oversold technical conditions and positive trend indicators. However, the bearish MACD signal and negative news sentiment may cap gains in the near term.
Recent news sentiment impact: The recent negative news headlines surrounding potential investigations and mergers have had a bearish impact on the stock price.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): Bullish, Medium-term (1-3 months): Bullish, Long-term (3-12 months): Bullish
Support/Resistance Levels: Key levels to monitor include the upper Bollinger Band ($3.75), SMA 20 ($1.81), and recent lows ($0.16).
Momentum Signals:
- RSI interpretation: Oversold (<30) with a reading of 25.14, indicating potential for a short-term rebound.
- MACD signal: Bearish crossover above the signal line (-0.56 / 0.00), suggesting further downside potential.
- Bollinger Bands position: Neutral, indicating no clear direction.
Volume Analysis: Volume is trending lower (134290.40) and has been declining since mid-April. Institutional interest is low, with a volume rate of change of -89.02%.
News & Sentiment Analysis
Recent Headlines Summary: The recent headlines have been overwhelmingly negative, suggesting potential for further downside pressure.
Sentiment Assessment: Aggregate news sentiment is NEGATIVE (5/10).
Catalyst Identification: No imminent catalysts are apparent, but ongoing investigations and merger discussions could impact the stock price in the near term.
Market Narrative: The technical signals suggest a rebound may be due, while the news sentiment suggests further downside potential. This divergence highlights the need for caution when considering a buy or sell decision.
Risk & Volatility Assessment
Beta Interpretation: LSTA has a relatively low beta (0.72), indicating lower volatility compared to the broader market.
Volatility Regime: The stock is currently experiencing low volatility, with a historical volatility reading of 130.4% (HV60).
Options Market Signals: No options data available for analysis.
Downside Protection: Support levels are critical to monitor, particularly the recent lows ($0.16) and SMA 20 ($1.81).
Market Context & Positioning
Sector Performance: LSTA is performing poorly relative to its sector/market.
Institutional Activity: Institutional interest is low, with a volume rate of change of -89.02%.
Correlation Analysis: The stock has a low correlation (0.08) with the broader market, suggesting potential for independent price movements.
Relative Valuation: LSTA is trading within a relatively narrow range, suggesting limited upside potential in the near term.
Key Levels & Action Items
Critical Price Levels: Monitor the upper Bollinger Band ($3.75), SMA 20 ($1.81), and recent lows ($0.16) for support/resistance.
Breakout/Breakdown Levels: A breakdown below $0.16 could trigger further downside pressure, while a breakout above $3.75 could lead to significant gains.
Time-Sensitive Catalysts: No imminent catalysts are apparent, but ongoing investigations and merger discussions could impact the stock price in the near term.
Risk Management: Consider setting stop-loss levels at recent lows ($0.16) or SMA 20 ($1.81), depending on your risk tolerance and market conditions.
Please note that this analysis is based solely on the provided data and does not constitute investment advice.
Generated
News
All LSTA news →
BenzingaT3·4mo ago
GlobeNewswire Inc.T3·5mo ago
GlobeNewswire Inc.T3·5mo ago
GlobeNewswire Inc.T3·5mo ago
GlobeNewswire Inc.T3·5mo ago
GlobeNewswire Inc.T3·5mo ago
BenzingaT3·7mo ago
GlobeNewswire Inc.T3·7mo ago
GlobeNewswire Inc.T3·8mo ago
Showing 1–10 of 50
Page 1 of 5
LSTA Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 0.8875
Alpha: -18.62%
Correlation: 0.0866
R-Squared: 0.7%
Stock Volatility: 130.7%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Moderate volatility - stock generally follows market
Beta & Alpha Over Time
LSTA Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
LSTA Insider Trading (Form 4)
Latest: 2026-01-13Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-01-13 | Mohammad Azab | Director | Award (A) | +30,456 | — | EDGAR | |
| 2026-01-13 | Steven M Klosk | Director | Award (A) | +30,456 | — | EDGAR | |
| 2026-01-13 | Cynthia Louise Flowers | Director | Award (A) | +30,456 | — | EDGAR | |
| 2026-01-13 | James Nisco | SVP, Fin/Treas, Chief Actg Off | Mixed | +8,820 | $1.97 | -$12.2K | EDGAR |
| 2026-01-13 | Heidi Henson | Director | Award (A) | +30,456 | — | EDGAR | |
| 2026-01-13 | Gregory B Brown | Director | Award (A) | +30,456 | — | EDGAR | |
| 2026-01-13 | David J Mazzo | President & CEO | Mixed | +39,904 | $1.97 | -$81.0K | EDGAR |
| 2026-01-13 | Tariq Imam | SVP, Bus Dev, General Counsel | Mixed | +11,499 | $1.97 | -$6.9K | EDGAR |
| 2026-01-13 | Kristen K Buck | EVP, R&D and CMO | Mixed | +13,668 | $1.97 | -$22.3K | EDGAR |
| 2025-01-13 | Mohammad Azab | Director | Award (A) | +15,789 | — | EDGAR | |
| 2025-01-13 | Steven M Klosk | Director | Award (A) | +15,789 | — | EDGAR | |
| 2025-01-13 | David J Mazzo | President & CEO | Mixed | +50,538 | $3.79 | -$115.5K | EDGAR |
| 2025-01-13 | Kristen K Buck | EVP, R&D and CMO | Mixed | +17,122 | $3.80 | -$29.9K | EDGAR |
| 2025-01-13 | Cynthia Louise Flowers | Director | Award (A) | +15,789 | — | EDGAR | |
| 2025-01-13 | Heidi Henson | Director | Award (A) | +15,789 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
LSTA Insider Holdings
9 insiders · @ $1.06
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | David J Mazzo | President & CEO | 319,744 | $338.9K | $0 | 8 | 2026-01-13 |
| 2 | Mohammad Azab | Director | 104,925 | $111.2K | $0 | 5 | 2026-01-13 |
| 3 | Steven M Klosk | Director | 95,815 | $101.6K | $0 | 4 | 2026-01-13 |
| 4 | Gregory B Brown | Director | 95,659 | $101.4K | $0 | 4 | 2026-01-13 |
| 5 | Kristen K Buck | EVP, R&D and CMO | 95,609 | $101.3K | $0 | 6 | 2026-01-13 |
| 6 | Cynthia Louise Flowers | Director | 95,446 | $101.2K | $0 | 4 | 2026-01-13 |
| 7 | Heidi Henson | Director | 85,725 | $90.9K | $0 | 4 | 2026-01-13 |
| 8 | Tariq Imam | SVP, Bus Dev, General Counsel | 38,178 | $40.5K | $0 | 1 | 2026-01-13 |
| 9 | James Nisco | SVP, Fin/Treas, Chief Actg Off | 32,311 | $34.2K | $0 | 3 | 2026-01-13 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
LSTA Board & Officers
As of SEC filings through Oct 15, 2026Directors 8
- Steven M Klosk · since Jul 8, 2014
- David J Mazzo · since Jan 5, 2015
- Gregory B Brown · since Oct 10, 2016
- Cynthia Louise Flowers · since Nov 7, 2018
- Heidi Henson · since Sep 15, 2022
- Mohammad Azab · since Sep 15, 2022
- Ted W Love · since Sep 17, 2026
- Jeffrey S Farrow · since Oct 13, 2026
Officers 5
- David J Mazzo · President & CEO · listed since Oct 2024
- Joshua Lehrer-Graiwer · President & COO · since Sep 17, 2026
- James Nisco · SVP, Fin/Treas, Chief Actg Off · since Apr 15, 2024
- Tariq Imam · SVP, Bus Dev, General Counsel · since Feb 3, 2025
- Kristen K Buck · EVP, R&D and CMO · since Sep 1, 2021
Changes in the last 10 years (30)
| Oct 13, 2026 | Jeffrey S Farrow became a director |
| Sep 17, 2026 | Ted W Love became a director |
| Sep 17, 2026 | Joshua Lehrer-Graiwer became President & COO |
| Feb 3, 2025 | Tariq Imam became SVP, Bus Dev, General Counsel |
| Oct 2, 2024 | David J Mazzo listed as President & CEO (previously Chief Executive Officer) in SEC filings |
| Apr 15, 2024 | James Nisco became SVP, Fin/Treas, Chief Actg Off |
| Jul 11, 2023 | The company announced the departure of Erkki Ruoslahti from the board in an SEC filing |
| May 1, 2023 | The company announced the departure of David W. Slack from the board in an SEC filing |
| May 1, 2023 | The company announced the departure of David W. Slack as President & CBO in an SEC filing |
| Sep 15, 2022 | Mohammad Azab became a director |
| Sep 15, 2022 | Heidi Henson became a director |
| Sep 15, 2022 | Erkki Ruoslahti became a director |
| Sep 15, 2022 | David W. Slack became a director |
| Sep 15, 2022 | David W. Slack became President & CBO |
| Sep 14, 2022 | The company announced the departure of Steven S Myers from the board in an SEC filing |
| Sep 14, 2022 | The company announced the departure of Steven S Myers from the board in an SEC filing |
| Sep 14, 2022 | The company announced the departure of Peter G Traber from the board in an SEC filing |
| Sep 14, 2022 | The company announced the departure of Michael H. Davidson from the board in an SEC filing |
| Sep 14, 2022 | The company announced the departure of Anne Clem Whitaker from the board in an SEC filing |
| Feb 24, 2022 | The company announced the departure of Todd C Girolamo as CLO, SVP of Corp Dev in an SEC filing |
| Sep 1, 2021 | Kristen K Buck became EVP, R&D and CMO |
| Jun 17, 2021 | Todd C Girolamo became CLO, SVP of Corp Dev |
| Nov 1, 2020 | Anne Clem Whitaker became a director |
| Jul 28, 2020 | Michael H. Davidson became a director |
| Nov 7, 2018 | Cynthia Louise Flowers became a director |
| Jan 10, 2018 | Steven S Myers first listed as a director in an SEC filing |
| Mar 22, 2017 | Sanford became a 10% owner |
| Mar 22, 2017 | Health Sanford became a 10% owner |
| Mar 16, 2017 | Robert A Preti left the board, per their own SEC filing |
| Mar 16, 2017 | Robert A Preti left as officer, per their own SEC filing |
Not reported recently (6)
- Joseph Talamo · Last reported as SVP and CFO in an SEC filing dated Jan 15, 2020
- Douglas W Losordo · Last reported as Chief Medical Officer in an SEC filing dated Jan 15, 2020
- Sanford · Last reported as a 10% owner in an SEC filing dated Mar 23, 2017
- Health Sanford · Last reported as a 10% owner in an SEC filing dated Mar 23, 2017
- Eric Wei · Last reported as a director in an SEC filing dated Feb 8, 2017
- Richard J Berman · Last reported as a director in an SEC filing dated Jan 31, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
4 ETFs hold LSTA
4 shown · $391.52K total exposure · 0.00% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $275,574 | — | 2026-09-30 |
| 2 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $115,839 | — | 2026-09-30 |
| 3 | DFSU Dimensional US Sustainability Core 1 ETF | Dimensional | 0.00% | $100 | $2.4B | 2026-10-23 |
| 4 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.00% | $8 | — | 2026-10-23 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.